- Coordinator
- Servicio Madrileno De Salud, Spain
- Runs
- 1 January 2025 to 31 December 2030
- Status
- Running
- EU funding
- €31.5m
- Total cost
- €68.7m
- Partners
- 89 organisations in 20 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101166227
What the project is doing
In the project's own words, from its summary on CORDIS.
The public-private partnership, READI, seeks to help clinical studies (CS) to finally serve the complete general population, and therefore more patients. To date CS have struggled to recruit and retain participants from diverse backgrounds and communities, such as marginalized or disadvantaged groups (e.g., sexual, gender, age, cultural, and socioeconomic cohorts). The resulting knowledge gaps entrench or increase health disparities.
The READI consortium strives to tackle these challenges by fostering a more cohesive and integrated CS ecosystem for underserved (US) and underrepresented (UR) communities. It will actively connect all key stakeholders who can facilitate access to a wide range of patient populations. It will provide these stakeholders with the necessary tools, training programs, and approaches essential for the recruitment and retention of US/UR patients in CS.In addition, it will design, build and implement a digital platform which is patient-centred, sustainable, open and innovative.
This will foster improved access to CS information and READI tools, while also supporting patient connections with the created communities. Finally, at least 4 CS will be used for testing the effectiveness of the developed tools and approaches. READI has a three-fold objective: to help US/UR communities overcome CS participation barriers (e.g., lack of information/awareness, mistrust, poor communication, geographic limitations, prejudice), which in turn will improve research of many diseases and conditions, preventative care and treatment effectiveness in different demographic groups, and better serve society.
READI’s success will draw from its interdisciplinary, multi-stakeholder, consortium composition of 88 organizations from 20 countries, with key expertise in drug development and CS (design and operations), engagement strategies for US/UR populations, digital platform development, training and capability building initiatives, effective communication and dissemination, long-term sustainability, ethics and regulatory affairs.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Servicio Madrileno De Salud | Madrid | Spain | Coordinator |
| Ablynx NV | Zwijnaarde | Belgium | Associatedpartner |
| Amgen | Diegem | Belgium | Participant |
| Cdisc Europe Foundation Fondation | Bruxelles / Brussel | Belgium | Participant |
| Curewiki | Brussels | Belgium | Participant |
| Digestive Cancers Europe Dice | Bruxelles / Brussel | Belgium | Participant |
| Esperity | Bruxelles / Brussel | Belgium | Participant |
| Forum Des Patients Europeens | Bruxelles / Brussel | Belgium | Participant |
| Hl7 Europe | Bruxelles / Brussel | Belgium | Participant |
| Janssen Pharmaceutica NV | Beerse | Belgium | Third party |
| Synergist Services | Bruxelles / Brussel | Belgium | Participant |
| The Synergist | Bruxelles / Brussel | Belgium | Participant |
| Ucb Biopharma | Bruxelles / Brussel | Belgium | Participant |
| Sanofi Medley Farmacêutica Ltda | São Paulo | Brazil | Associatedpartner |
| F. Hoffmann-La Roche AG | Basel | Switzerland | Participant |
| Novartis Pharma AG | Basel | Switzerland | Participant |
| Takeda Pharmaceuticals International AG | Glattpark | Switzerland | Participant |
| Edex - Educational Excellence Corporation Limited | Nicosia | Cyprus | Participant |
| European University - Cyprus Ltd | Nicosia | Cyprus | Participant |
| Abbvie Deutschland GmbH & Co Kg | Wiesbaden | Germany | Associatedpartner |
| Boehringer Ingelheim Internationalgmbh | Ingelheim | Germany | Participant |
| European Aids Treatment Group eV | Dusseldorf | Germany | Participant |
| Janssen-Cilag GmbH | Neuss | Germany | Third party |
| Klinikum Der Universitaet Zu Koeln | Koeln | Germany | Participant |
| Lilly Deutschland GmbH | Bad Homburg | Germany | Associatedpartner |
| Aarhus Universitet | Aarhus C | Denmark | Participant |
| Aarhus Universitetshospital | Aarhus | Denmark | Participant |
| Fonden for Almen Praksis S/i | Kobenhavn O | Denmark | Third party |
| Midtjyllands EU Kontor Forening | Viborg | Denmark | Participant |
| Novo Nordisk A/s | Bagsvaerd | Denmark | Participant |
| Trial Nation | Copenhagen | Denmark | Participant |
| Almirall SA | Barcelona | Spain | Participant |
| Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I Sunyer | Barcelona | Spain | Third party |
| Fundacio Privada per a La Recerca I La Docencia Sant Joan De Deu | Esplugues De Llobregat | Spain | Participant |
| Fundacion 29 De Febrero | Pozuelo De Alarcon Madrid | Spain | Participant |
| Fundacion Centro De Tecnologias De Interaccion Visual Y Comunicaciones Vicomtech | Donostia San Sebastian | Spain | Participant |
| Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana | Valencia | Spain | Participant |
| Fundacion Para La Investigacion Biomedica Del Hospital Universiatrio La Paz | Madrid | Spain | Third party |
| Fundacion Para La Investigacion Biomedica Del Hospital Universitario De Getafe | Madrid | Spain | Third party |
| Janssen Cilag SA | Madrid | Spain | Associatedpartner |
| Pfizer SLU | Madrid | Spain | Associatedpartner |
| Sanofi Aventis SA | Barcelona | Spain | Associatedpartner |
| Synapse Research Management Partners SL | Madrid | Spain | Participant |
| Zabala Innovation Consulting SA | Mutilva Alta Navarra | Spain | Participant |
| Ecrin European Clinical Research Infrastructure Network | Paris | France | Participant |
| Pfizer International Operations | Paris | France | Associatedpartner |
| Sanofi R&d Vaccins | Lyon | France | Associatedpartner |
| Sanofi Winthrop Industrie | Gentilly | France | Associatedpartner |
| Sanofi-Aventis Recherche & Developpement | Gentilly | France | Participant |
| Chinoin Private Co Ltd | Budapest | Hungary | Associatedpartner |
| Eli Lilly Kinsale Ltd | Cork | Ireland | Associatedpartner |
| Global Heart Hub Company Limited by Guarantee | Galway | Ireland | Participant |
| Irish Platform for Patients' Organisations Science and Industry Limited by Guarantee | Dublin | Ireland | Participant |
| Chiesi Farmaceutici SpA | Parma | Italy | Participant |
| Fondazione Penta Ets | Padova | Italy | Participant |
| Socialit Software E Consulting SRL | Trento | Italy | Participant |
| Sanofi Srl | Milano | Italy | Associatedpartner |
| Nacionalinis Vezio Institutas | Vilnius | Lithuania | Participant |
| Pagalbos Onkologiniams Ligoniams Asociacija | Kaunas | Lithuania | Participant |
| Information Technology for Translational Medicine (ittm) SA | Esch-Uelzecht | Luxembourg | Participant |
And 29 more organisations. Full list on CORDIS.
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI